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Cadmium is a highly toxic and carcinogenic 
metal widely distributed in the environment. 
Mounting evidence from general populations 
exposed to low or moderate levels points to 
cadmium as a risk factor for a broad spectrum 
of health conditions, including cardiovascular, 
kidney, and bone disease (Järup and Akesson 
2009; Nordberg et al. 2007; Satarug et al. 
2010). Smoking, diet (leafy and root vegeta-
bles, grains, and offal), ambient air, and occu-
pation exposures (metal and mining industry, 
transportation, and repairing services) are the 
main sources of cadmium exposure (Järup 
and Akesson 2009; Nordberg et al. 2007; 
Satarug et al. 2010; Yassin and Martonik 
2004). Public health policies such as tobacco 
control [Breysse and Navas-Acien 2010; 
U.S. National Center for Health Statistics 
(NCHS) 2010b], air pollution reduction 
[U.S. Environmental Protection Agency 
(EPA) 2010a, 2010b], and hazardous waste 
remediation (U.S. EPA 2010c) may have 
resulted in decreased cadmium exposure in 
the U.S. population. In the U.S. population, 
however, trends in cadmium exposure over 
time have not been evaluated.
The National Health and Nutrition 
Examination Survey (NHANES) provides peri-
odic monitoring of the health of the U.S. popu-
lation. Since 1988, NHANES has included the 
measurement of cadmium concentrations in 
urine (NCHS 2010a). Urine cadmium is a bio-
marker of cumulative cadmium exposure and 
internal dose that reflects cadmium concentra-
tions in the renal cortex (Järup and Akesson 
2009; Nordberg et al. 2007). Our objective 
was to estimate trends in cadmium exposure, as 
measured by urine cadmium, in the general U.S. 
population from 1988 to 2008. In addition, we 
evaluated the impact of population changes in 
the distribution of cadmium determinants, in 
particular smoking, to explain changes in urine 
cadmium concentrations over time.
Materials and Methods
Study population. NHANES uses a complex 
multistage sampling design to obtain represen-
tative samples of the noninstitutionalized U.S. 
population (NCHS 2010a). We used data 
from NHANES III (1988–1994), collected 
in two phases (1988–1991 and 1991–1994), 
and from NHANES 1999–2008, collected 
in five phases (1999–2000, 2001–2002, 
2003–2004, 2005–2006, and 2007–2008). 
In NHANES III, urine cadmium was meas-
ured in all participants ≥ 6 years of age. In 
NHANES 1999–2008, urine cadmium was 
measured in a random one-third subsample of 
participants ≥ 6 years of age. For this analysis 
we included 23,904 adults ≥ 20 years of age 
(7,967 in 1988–1991, 8,169 in 1991–1994, 
1,299 in 1999–2000, 1,560 in 2001–2002, 
1,532 in 2003–2004, 1,520 in 2005–2006, 
and 1,857 in 2007–2008). We excluded 628 
pregnant women; 109 participants with miss-
ing urine creatinine measurements; 3,179 
participants with missing smoking status, 
pack-years, or serum cotinine; and 229 par-
ticipants with missing other variables of inter-
est. A total of 19,759 participants (6,616 in 
1988–1991, 7,075 in 1991–1994, 965 in 
1999–2000, 1,166 in 2001–2002, 1,209 in 
2003–2004, 1,160 in 2005–2006, and 1,568 
in 2007–2008) were included in our analy-
ses. Participants included in this analysis were 
similar to the corresponding NHANES-phase 
population with respect to sociodemographic 
variables (data not shown).
Urine cadmium. Cadmium in spot urine 
samples was measured at the Environmental 
Health Laboratory of the Centers for Disease 
Control and Prevention’s (CDC) National 
Center for Environmental Health (Atlanta, 
GA, USA) for all surveys. Extensive quality 
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Ba c k g r o u n d: Public health policies such as tobacco control, air pollution reduction, and   hazardous 
waste remediation may have reduced cadmium exposure among U.S. adults. However, trends in 
urine cadmium, a marker of cumulative cadmium exposure, have not been evaluated.
oBjectives: We estimated the trends in urine cadmium concentrations in U.S. adults using data 
from the National Health and Nutrition Examination Surveys (NHANES) from 1988 to 2008. We 
also evaluated the impact of changes in the distribution of available cadmium determinants (age, 
sex, race, education, body mass index, smoking, and occupation) at the population level to explain 
cadmium trends.
Me t h o d s : The study population included 19,759 adults ≥ 20 years of age with measures of urine 
cadmium and cadmium determinants.
re s u l t s: Age-adjusted geometric means of urine cadmium concentrations were 0.36, 0.35, 0.27, 
0.27, 0.28, 0.25, and 0.26 µg/g creatinine in 1988–1991, 1991–1994, 1999–2000, 2001–2002, 
2003–2004, 2005–2006, and 2007–2008, respectively. The age, sex, and race/ethnicity-adjusted 
percent reduction in urine cadmium geometric means comparing 1999–2002 and 2003–2008 with 
1988–1994 were 27.8% (95% confidence interval: 22.3%, 32.9%) and 34.3% (29.9%, 38.4%), 
respectively (p-trend < 0.001), with reductions in all participant subgroups investigated. In never 
smokers, reductions in serum cotinine accounted for 15.6% of the observed reduction. In ever 
smokers, changes in smoking cessation, and cumulative and recent dose accounted for 17.1% of the 
observed reduction.
co n c l u s i o n s: Urine cadmium concentrations decreased markedly between 1988 and 2008. 
Declining smoking rates and changes in exposure to tobacco smoke may have played an important 
role in the decline of urine cadmium concentrations, benefiting both smokers and nonsmokers. 
Cadmium has been associated to several health outcomes in NHANES 1999–2008. Consequently, 
despite the observed decline, further reduction in cadmium exposure is needed.
key w o r d s : cadmium, cigarette smoking, determinants, NHANES, trends. Environ Health Perspect 
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control procedures were followed, including 
confirmation that collection and storage mate-
rials were not contaminated with background 
cadmium or other metals (NCHS 2010a).
Urine cadmium was measured by graph-
ite furnace atomic absorption spectrometry 
(model 3030; PerkinElmer, Norwalk, CT, 
USA) with Zeeman background correction in 
NHANES 1988–1994, by inductively coupled 
plasma mass spectrometer (ICP-MS; ELAN, 
PerkinElmer) in NHANES 1999–2002, and 
by ICP–dynamic reaction cell (DRC)-MS 
(ELAN DRC, PerkinElmer) in NHANES 
2003–2008 (NCHS 2010a). In NHANES 
1988–1994, specimens were analyzed in dupli-
cate, and the average of the two measurements 
was reported (Paschal et al. 2000). The interas-
say coefficients of variation ranged from 2.8% 
to 13.6%, and the limit of detection (LOD) 
was 0.03 µg/L (NCHS 2010a), resulting in 6% 
of observations below the LOD. In NHANES 
1999–2008, the interassay coefficients of varia-
tion for urine cadmium ranged from 1.2% 
to 6.7%, and the LOD was 0.06 µg/L in 
1999–2004 and 0.042 µg/L in 2005–2008, 
resulting in 4% of observations below the 
LOD. In all phases, the urine reference mate-
rial from the National Institute of Standards 
and Technology (NIST 2010) was analyzed 
periodically to ensure analytical accuracy, and 
observed concentrations were in good agree-
ment with published values (96–101%) (Jarrett 
et al. 2008; Paschal et al. 2000). Two levels of 
in-house urine pools traceable to the reference 
material were used for daily quality control. 
One of two different levels of a blind quality 
control material was inserted in every analyti-
cal group of samples for an additional quality 
control check. In NHANES III, laboratory 
measures were within 10% of reference means 
for urinary cadmium (r2 = 0.97) (Paschal et al. 
2000). Precision data for NHANES 1999–
2008 are discussed in detail in Jarrett et al. 
(2008). In brief, NHANES 1999–2002 data 
were mathematically adjusted to eliminate a 
bias in the original standard-mode quadrupole 
ICP-MS data caused by a molybdenum-based 
interference. The CDC lab used a new ICP-
DRC-MS method starting in the NHANES 
2003–2004 cycle to eliminate the molybde-
num oxide interference. Therefore, starting 
with the 2003–2004 survey cycle, the need for 
mathematical correction of the urine cadmium 
data was eliminated (Jarrett et al. 2008). For 
observations below the LOD and for values 
corrected for interference from molybdenum 
oxide equal to 0 in 1999–2002 data (n = 4), 
urine cadmium value was imputed as the LOD 
divided by the square root of 2 (Hornung and 
Reed 1990).
Creatinine-corrected urine cadmium data 
were reported in micrograms cadmium per 
gram creatinine. Urine creatinine was meas-
ured by the modified kinetic Jaffé method 
in 1988–2006 and by an enzymatic (creati-
nase) method in 2007–2008 (NCHS 2010a). 
We corrected urine creatinine determinations 
before 2007 as recommended by NHANES 
(NCHS 2010a).
Urine cadmium determinants. Information 
on age, sex, race/ethnicity, education, smoking 
status, cigarette pack-years, occupation, body 
mass index (BMI), and serum cotinine was 
based on questionnaires, physical examina-
tion, and laboratory methods that have been 
described elsewhere (Benowitz et al. 1983; 
NCHS 2010a; Yassin and Martonik 2004). 
We classified study participants as current 
smokers if they answered yes to the question 
“Do you smoke cigarettes now?” or had serum 
cotinine levels > 10 ng/mL (Benowitz et al. 
1983). Former smokers were participants 
who answered yes to the question “Have you 
smoked at least 100 cigarettes during your 
entire life?” but were not current smokers. 
Pack-years were determined using answers to 
the following questions: “How old were you 
when you first started smoking cigarettes fairly 
regularly?”, “About how many cigarettes do you 
smoke per day now?” (or, because of changes 
in the smoking questionnaires in NHANES 
2007–2008, “Average number of cigarettes/
day during the past 30 days”), “For approxi-
mately how many years have you smoked this 
amount?”, “About how old were you when 
you last smoked cigarettes (fairly regularly)?”, 
and “About how many cigarettes per day did 
you usually smoke at that time?”
Occupations and industries associated with 
cadmium exposure were based on the study by 
Yassin and Martonik (2004) and included self-
reported occupations related to transportation, 
metal, mining, and repairing service industries. 
Duration of the longest cadmium-associated 
occupation was determined using answers to 
the questions: “What kind of work were you 
doing (in the past 1 or 2 weeks, depending on 
the survey period)?”, “About how long have 
you worked for (employer) as a(n) (occupation) 
(in the past 1 or 2 weeks, depending on the 
survey period)?”, “Thinking of all the paid jobs 
or businesses you ever had, what kind of work 
were you doing the longest?”, and “About how 
long did you work at that job or business (the 
longest)?” For participants with the longest held 
job not being cadmium related, the current 
job was also considered as a potential source of 
cadmium. Information on occupation was not 
available in NHANES 2005–2008.
Serum cotinine was measured by an isotope-
dilution high-performance liquid chromatogra-
phy/atmospheric pressure chemical ionization 
tandem MS method (NCHS 2010a). The 
LOD for serum cotinine was 0.05 ng/mL in 
NHANES III and 0.015 ng/mL in NHANES 
1999–2008. For the 4.9% and 9.0% of par-
ticipants below the LOD in NHANES III and 
NHANES 1999–2008, respectively, cotinine 
concentrations were replaced by the LOD 
divided by the square root of 2.
Statistical methods. Statistical analyses 
were performed using the survey package 
(Lumley 2004) in R software (version 2.12.1; 
R Development Core Team 2011) to account 
for the complex sampling design and weights 
in NHANES 1988–2008 and to obtain appro-
priate standard errors for all estimates. Urine 
cadmium levels were right skewed and were 
log transformed for the analyses. Age-adjusted 
cadmium concentrations were obtained using 
the residuals from linear regression models of 
log-urine cadmium concentrations corrected 
for creatinine modeled by age as restricted 
cubic splines with 5 knots, and adding back 
the cadmium-weighted means of the corre-
sponding NHANES samples. Age-adjusted 
creatinine-corrected urine cadmium concen-
trations were reported as geometric means.
Starting in 1999, urine cadmium was 
measured in a one-third random subsample of 
NHANES participants only. To increase the 
sample size in regression models over time, we 
grouped multiple phases together (1988–1994, 
1999–2002, and 2003–2008). Temporal 
trends in urine cadmium concentrations were 
evaluated by estimating geometric mean ratios 
and 95% confidence intervals (CIs) of urine 
cadmium concentrations in NHANES 1999–
2002 and NHANES 2003–2008 compared 
with NHANES 1988–1994. The geometric 
mean ratios were obtained by exponentiating 
linear combinations of β-coefficients in regres-
sion models adjusted for age, sex, and race/
ethnicity with log-transformed cadmium as the 
dependent variable and survey phase group and 
cadmium determinants as interacting indepen-
dent variables. Subsequently, percent reduc-
tions in geometric means over time [estimated 
as (1 – geometric mean ratio) × 100] and 95% 
CIs were calculated overall and by subgroups 
of cadmium determinants. We considered 
the following subgroups of cadmium deter-
minants: age (< 35, 35–49, 50–65, and ≥ 65 
years), sex (men and women), race/ethnicity 
(white, African American, Mexican American, 
and other), education (< high school and 
high school, or higher education), BMI (< 25, 
25–30, and ≥ 30 kg/m2), cigarette smoking 
status (never, former, current), cigarette pack-
years (0, 0–10, 10–20, and > 20 pack-years), 
serum cotinine (< 0.05, 0.05–10, 10–200, 
≥ 200 ng/mL), and duration of the longest 
occupation associated to cadmium (0, 0–10, 
10–20, > 20 years in the subset of participants 
with information available). We estimated 
p-trend values by applying the Wald test to the 
appropriate regression coefficients.
Toxicokinetic parameters related to cad-
mium absorption, accumulation in the renal 
cortex, and excretion, such as low iron stores 
or reduced kidney function, could induce 
variation in urine cadmium concentrations Tellez-Plaza et al.
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independently of variations in exposure (Amzal 
et al. 2009; Ruiz et al. 2010). Therefore, we 
performed a sensitivity analysis using mod-
els adjusted for serum iron, and glomerular 
filtration rate, in addition to age, sex, and 
race/  ethnicity. Results were similar to those 
reported here (data not shown).
The relative contribution of cadmium 
determinants to the trend in urine cad-
mium concentrations was calculated as the 
relative change in the β-coefficient for sur-
vey phase category (grouped as 1999–2008 
vs. 1988–1994) in regression models for 
log-transformed cadmium after sequentially 
introducing cadmium determinants in linear 
regression models. In this analysis, NHANES 
1999–2002 and 2003–2008 were combined 
and compared with NHANES 1988–1994 for 
simplicity, because results in NHANES 1999–
2002 and NHANES 2003–2008 separately 
yielded similar findings. Because occupation 
variables were available only until 2004, the 
contribution of occupation to the change in 
urine cadmium concentrations was evaluated 
only for the available period.
We also conducted a sensitivity analysis 
comparing estimates from models of urine cad-
mium concentrations (micrograms per liter) 
adjusted for log-transformed urine creatinine 
(data not shown) with those from models of 
creatinine-corrected urine cadmium concen-
trations (micrograms per gram). Results were 
comparable to those reported here.
Results
Participant characteristics. Between 1988 and 
2008, the U.S. population became older and 
more educated, and its average BMI increased 
[see Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1104020)]. The preva-
lence of never smokers increased from 46.0% in 
1988–1994 to 53.8% in 2003–2008, whereas 
cigarette pack-years (mean, 12.9 vs. 10.1 pack-
years) and serum cotinine concentrations (geo-
metric mean, 1.44 vs. 0.34 ng/mL) decreased 
markedly in the overall population.
Cadmium determinants. Age-, sex-, and 
race/ethnicity-adjusted geometric mean urine 
cadmium concentrations were higher with 
increasing age, in women compared with men, 
in former and current smokers compared with 
never smokers, with increasing cigarette pack-
years and serum cotinine concentrations, and 
in participants with a cadmium-  associated 
occupation during all three time periods 
[1988–1994, 1999–2002, 2003–2008; see 
Supplemental Material, Table 2 (http://dx.doi.
org/10.1289/ehp.1104020)]. The strength 
of the association between determinants and 
urine cadmium concentrations was similar 
across survey periods for all variables except 
race/ethnicity (African-American participants 
had increased urine cadmium concentrations 
compared with whites in 1988–1994 but not 
in 2003–2008).
Cadmium trends. The distribution of 
age-adjusted urine cadmium concentrations 
shifted progressively downward over time 
(Figure 1). Age-adjusted geometric mean urine 
cadmium concentrations were 0.36, 0.35, 
0.27, 0.27, 0.28, 0.25, and 0.26 µg/g creati-
nine in 1988–1991, 1991–1994, 1999–2000, 
2001–2002, 2003–2004, 2005–2006, and 
2007–2008, respectively. The decrease in age-
adjusted geometric mean of urine cadmium 
concentrations was observed in both men 
and women and among never, former, and 
current smokers [see Supplemental Material, 
Figure 1, Table 3 (http://dx.doi.org/10.1289/
ehp.1104020)]. The overall prevalence of 
urine cadmium concentrations > 1 µg/g g 
[2009 tolerable weekly intake reference point, 
European Food Safety Authority Panel (EFSA) 
2011)] was 16.04%, 4.53%, and 4.56% in 
1988–1994, 1999–2002, and 2003–2008, 
respectively, although the observed decline was 
progressive over the study period in most sub-
groups, for example, in men, whites, African 
Americans, Mexican Americans, and never and 
current smokers (see Supplemental Material, 
Table 4).
Compared with 1988–1994, the age-, sex-, 
and race/ethnicity-adjusted percent reduc-
tions in the geometric means of urine cad-
mium concentrations were 27.8% and 34.3% 
in 1999–2002 and 2003–2008, respectively 
(Table 1), with reductions observed in all par-
ticipant subgroups investigated. Older partici-
pants, African Americans, participants with less 
than high school education, obese participants, 
and former smokers and smokers in the highest 
cigarette pack-year and serum cotinine catego-
ries showed larger percent reductions compared 
with other groups.
Contribution of cadmium determinants 
to the trend. The reduction in the geometric 
mean of urine cadmium concentration between 
1999–2008 and 1988–1994 was attenuated 
after additional adjustment for smoking sta-
tus, pack-years, and serum cotinine [21.7% 
(95% CI: 17.4%, 25.9%) compared with 
29.5% (25.1%, 33.6%) when adjusted for 
age, sex, race/ethnicity, education, and BMI 
only; Table 2]. Smoking-related variables thus 
accounted for 26.4% of the observed reduc-
tion in urine cadmium concentrations compar-
ing the fully adjusted model with and without 
smoking variables ([1 – (21.7/29.5)] × 100). 
In analyses restricted to never smokers, serum 
cotinine concentrations accounted for 15.6% of 
the corresponding reduction in urine cadmium 
concentrations (23.7% vs. 20.0% reduction 
before and after adjustment for serum   cotinine). 
In ever smokers (i.e., current and former smok-
ers), smoking-related variables accounted for 
17.1% of the corresponding reduction in urine 
cadmium concentrations (29.8% vs. 24.7% 
reduction before and after adjustment for cur-
rent and former smoking status, pack-years, 
and serum cotinine). The coefficient of deter-
mination (R2) for the fully adjusted model was 
0.46. Changes in cadmium-related occupations 
did not explain cadmium exposure trends in the 
subsample of the population with occupational 
data available, as results did not change before 
and after adjustment for occupation variables 
(data not shown).
Discussion
Urine cadmium concentrations decreased by 
34.3% from 1988–1994 to 2003–2008 in 
the U.S. adult population after adjustment for 
age, sex, and race/ethnicity. The reduction in 
adjusted urine cadmium concentrations was 
observed in all population subgroups evaluated, 
but it was stronger in ever smokers, heavier 
Figure 1. Distribution of age-adjusted urine cadmium in NHANES 1988–1994, 1999–2002, and 2003–2008. 
Urine cadmium concentrations were adjusted for age (years modeled as restricted cubic spline with 
5 knots) in survey-period–specific strata.
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smokers, and African Americans compared 
with other subgroups. We identified the reduc-
tion in smoking rates as a key factor driving 
the reduction in urine cadmium over time. 
A large proportion of the reduction in urine 
cadmium concentrations, however, remained 
unexplained and could be related to changes in 
cadmium concentrations in ambient air, food, 
or other determinants not available in our sur-
vey. Given the multiple health consequences of 
cadmium exposure (Järup and Akesson 2009; 
Nordberg et al. 2007; Satarug et al. 2010), the 
decline of urine cadmium levels documented 
in the present analysis is an important public 
health achievement. Cadmium exposure, how-
ever, is still too high, because cadmium in the 
environment is mostly coming from anthropo-
genic sources [Agency for Toxic Substances and 
Disease Registry (ATSDR) 1999], and cad-
mium production was practically nonexistent 
as recently as the beginning of the 20th century 
[U.S. Geological Survey (USGS) 2010].
Cadmium was discovered in the 19th cen-
tury (USGS 2010). A by-product from min-
ing, from smelting, and from refining zinc, 
lead, and copper ores, cadmium industrial pro-
duction started in the 1930s [ATSDR 1999; 
International Agency for Research on Cancer 
(IARC) 1993; USGS 2010]. Since then, the 
use of cadmium in consumer products (e.g., 
pigments, batteries, coatings, and plastic sta-
bilizers) increased dramatically until the 1970s 
and 1980s (ATSDR 1999; Nordberg et al. 
2007; USGS 2010), resulting in widespread 
soil contamination from industrial releases, 
fuel combustion, and cadmium-containing 
phosphate fertilizers (ATSDR 1999; Lalor 
2008; Nordberg et al. 2007; Staessen et al. 
1992). Soil contamination by cadmium is a 
major environmental health problem because 
leafy and root vegetables and grains bio-
concentrate cadmium from soil (Dal Corso 
et al. 2008; Huang et al. 2008), providing 
a major pathway for exposure through diet 
and tobacco (Golia et al. 2009; Lalor 2008; 
Nordberg et al. 2007). Ambient air and dust 
can also contribute to cadmium exposure, par-
ticularly in urban areas and in the vicinity of 
industrial sources and waste sites (Hogervorst 
et al. 2007; Nordberg et al. 2007).
Urine cadmium concentrations in U.S. 
adults were lower than concentrations measured 
in northeastern Belgium (Nawrot et al. 2008) 
and nationwide surveys from Canada (Wong 
and Lye 2008), Japan (Ikeda et al. 2000), and 
Korea (Lee et al. 2010) but similar to concen-
trations in a nationwide survey from Germany 
(Schulz et al. 2007). Data on cadmium trends 
in population-based samples are scarce (Nawrot 
et al. 2008; Schulz et al. 2007). In northeast-
ern Belgium, 24-hr urine cadmium concentra-
tions decreased by 12.9% from 1985 to 1996, 
and blood cadmium concentrations decreased 
by 20% from 1985 to 2001–2003 (Nawrot 
Table 1. Urine cadmium levels over time by participant characteristics.a,b
Urine cadmium, geometric mean (µg/g)
Percent reduction of geometric mean (CI)c
1999–2002 vs. 
1988–1994
2003–2008 vs. 
1988–1994 Characteristic n 1988–1994 1999–2002 2003–2008
Overall 19,759 0.37 0.27 0.24 27.8 (22.3, 32.9) 34.3 (29.9, 38.4)
Age group (years)
< 35 5,676 0.2 0.15 0.14 23.0 (14.9, 30.3) 30.5 (23.7, 36.8)
35–50 5,231 0.36 0.27 0.25 25.0 (16.0, 33.0) 32.2 (25.2, 38.6)
50–65 4,045 0.6 0.41 0.37 31.9 (24.1, 38.9) 38.8 (33.3, 43.8)
≥ 65 4,807 0.69 0.44 0.44 35.5 (30.3, 40.2) 35.6 (30.4, 40.4)
Sex
Men 9,360 0.31 0.22 0.21 29.0 (22.8, 34.7) 33.5 (28.5, 38.1)
Women 10,399 0.44 0.32 0.28 26.7 (20.3, 32.6) 35.0 (29.9, 39.7)
Race/ethnicity
White 8,734 0.36 0.26 0.24 27.5 (20.3, 34.0) 33.2 (27.4, 38.5)
African American 4,830 0.41 0.27 0.24 35.1 (26.1, 43.1) 42.2 (38.2, 46.0)
Mexican American 5,061 0.38 0.29 0.26 23.2 (14.7, 30.9) 32.8 (27.2, 37.9)
Other 1,134 0.44 0.33 0.29 25.3 (13.0, 35.8) 34.3 (23.6, 43.5)
Education
≥ High school 12,485 0.35 0.26 0.24 26.7 (20.6, 32.3) 32.1 (27.2, 36.6)
< High school 7,274 0.46 0.33 0.29 28.7 (21.6, 35.2) 37.1 (31.7, 42.0)
BMI (kg/m2)
< 25 7,217 0.38 0.31 0.27 19.3 (8.8, 28.5) 28.8 (21.9, 35.2)
25–30 6,996 0.38 0.26 0.24 31.4 (24.7, 37.4) 35.0 (28.8, 40.7)
≥ 30 5,546 0.35 0.24 0.22 30.9 (24.4, 36.9) 37.4 (32.7, 41.8)
Smoking
Never 10,107 0.27 0.21 0.19 22.1 (15.4, 28.4) 28.4 (22.7, 33.8)
Former 4,524 0.38 0.27 0.25 29.8 (22.3, 36.5) 35.7 (29.8, 41.0)
Current 5,128 0.6 0.47 0.41 22.2 (13.7, 29.9) 32.4 (26.4, 37.8)
Pack-years
0 10,177 0.26 0.21 0.19 21.1 (14.5, 27.1) 27.0 (21.3, 32.3)
0–10 4,075 0.34 0.28 0.23 16.6 (5.8, 26.2) 31.2 (24.5, 37.3)
10–20 1,803 0.51 0.37 0.34 26.3 (14.8, 36.3) 32.5 (24.3, 39.9)
> 20 3,704 0.71 0.5 0.49 29.8 (23.1, 36.0) 31.4 (25.7, 36.8)
Serum cotinine (ng/mL)
< 0.05 4,578 0.25 0.22 0.2 13.3 (3.0, 22.5) 20.3 (11.1, 28.6)
0.05–10 10,328 0.32 0.24 0.22 25.3 (17.9, 32.1) 31.0 (25.5, 36.2)
10–200 2,062 0.45 0.4 0.34 11.3 (–1.8, 22.7) 24.2 (14.1, 33.1)
≥ 200 2,791 0.76 0.57 0.47 24.1 (15.0, 32.3) 38.2 (32.5, 43.3)
Duration of longest cadmium-associated occupation (years)d
0 17,480 0.36 0.26 0.25 26.9 (21.0, 32.3) 30.1 (24.1, 35.6)
0–10 3,904 0.43 0.32 0.33 27.1 (9.3, 41.3) 23.9 (11.1, 34.9)
10–20 3,476 0.47 0.35 0.35 26.2 (4.3, 43.1) 26.2 (0.5, 45.2)
> 20 3,578 0.51 0.34 0.31 33.5 (15.4, 47.8) 39.7 (23.7, 52.4)
aGeometric means and percent reductions in geometric means were adjusted for age (years modeled as restricted 
cubic splines with 5 knots), sex (men, women), and race/ethnicity (white, African American, Mexican American, and 
other). Geometric means were further recalibrated to overall mean. bp-Trend was < 0.001 overall and for all subgroups. 
cWe obtained adjusted ratios of geometric means comparing survey phase groups (NHANES 1999–2002 and 2003–2008) 
with respect to the reference survey phase group (NHANES 1988–1994) by exponentiating linear combinations of 
β-coefficients from regression models with log-transformed cadmium as the dependent variable and survey phase 
group and confounder factors as interacting independent variables. Subsequently, the percent reduction of the geo-
metric mean was estimated as (1 – ratio of geometric mean) × 100. For instance, a 28.7% reduction comparing urine 
cadmium concentrations in NHANES 1999–2002 to NHANES 1988–1994 corresponded to a ratio of geometric means 
comparing NHANES 1999–2002 with NHANES 1988–1994 equal to 0.713. p-Trends comparing 1999–2002 and 2003–2008 
with 1988–1994 were obtained using the Wald test. dOccupation variables were only available through 2004.
Table 2. Percent reduction (95% CI) in urine cadmium geometric means comparing 1999–2008 and 
1988–1994 in models with progressive degrees of adjustment.a
Model adjustments
Overall 
(n = 19,759)
Never smokers 
(n = 10,107)
Ever smokers 
(n = 9,652)
Age 31.3 (26.9, 35.5) 24.9 (18.9, 30.5) 31.4 (27.1, 35.5)
Age, sex, race, education, and BMI 29.5 (25.1, 33.6) 23.7 (18.2, 28.8) 29.8 (25.3, 34.0)
Age, sex, race, education, BMI, and smoking status 27.2 (22.9, 31.2) NA 30.5 (26.2, 34.5)b
Age, sex, race, education, BMI, smoking status, 
pack-year, and cotinine
21.7 (17.4, 25.9) 20.0 (14.1, 25.6)c 24.7 (20.4, 28.8)b
NA, not applicable. 
aThe change in the percent reduction in geometric means comparing urine cadmium concentrations in NHANES 1999–2008 
with those in NHANES 1988–1994 after introducing a given variable (or set of variables) is interpreted as the amount of 
the reduction in urinary cadmium that can be attributed to that variable (or set of variables). For instance, for the overall 
population, the age-adjusted percent reduction of geometric mean of urine cadmium in NHANES 1999–2008 compared with 
1988–1994 was 31.3%. After further adjustment for age, sex, race, education, and BMI, the percent reduction was 29.5%; 
that is, changes in those variables explained 5.7% of the age-adjusted percent reduction [1 – (29.5/31.3) × 100 = 5.7%]. 
bSmoking status in ever smokers only included former and current smokers.   cAdjusted for serum cotinine only in analysis 
restricted to never smokers.Tellez-Plaza et al.
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et al. 2008). In Germany, the geometric mean 
urine cadmium concentrations decreased from 
0.29 µg/L in 1990 to 0.24 µg/L in 1998, but 
no change was observed for blood cadmium 
(Schulz et al. 2007). In addition to urine, blood 
cadmium has been measured in NHANES 
participants since 1999. Given the lack of 
blood cadmium determinations in NHANES 
1988–1994, the trend in blood cadmium con-
centrations from 1988 to 2008 could not be 
evaluated in our study population.
Tobacco-control policies in recent decades 
have resulted in important reductions in smok-
ing prevalence and tobacco dose in the United 
States (NCHS 2010b; Pierce et al. 2011). Our 
study suggests that changes in smoking sta-
tus (never, former, current), cumulative dose 
(cigarette pack-years), and recent dose (serum 
cotinine) have played an important role in the 
decline of urine cadmium concentrations in the 
U.S. population, benefiting both smokers and 
never smokers. Among ever smokers, changes in 
smoking variables accounted for 17.1% of the 
observed reduction in urine cadmium concen-
trations comparing fully adjusted models with 
and without smoking variables. Cumulative 
and recent smoking dose mostly contributed to 
the observed reduction. Furthermore, heavier 
smokers (higher categories of pack-years and 
serum cotinine concentrations) presented larger 
urine cadmium reductions. These findings 
could be due to the decrease in the number 
of cigarettes smoked per day (O’Connor et al. 
2006; Pierce et al. 2011) and to changes in cig-
arette composition over time (Hoffmann et al. 
2001; Scherer and Barkemeyer 1983). Among 
never smokers, changes in serum cotinine, a 
marker of exposure to secondhand smoke, 
accounted for 15.6% of the adjusted reduction 
in urine cadmium concentrations comparing 
fully adjusted models with and without coti-
nine. Cadmium is present both in sidestream 
and mainstream tobacco smoke (Chang et al. 
2005; Kalcher et al. 1993; Pappas et al. 2006). 
Although data on secondhand smoke exposure 
as a source of cadmium exposure are scarce and 
inconsistent (Bolte et al. 2008; Conrad et al. 
2010; McElroy et al. 2007), our results suggest 
that reductions in secondhand smoke expo-
sure in recent decades have decreased cadmium 
exposure in U.S. adults. Additional tobacco-
control efforts may further reduce cadmium 
exposure in the population, including legislat-
ing and promoting smoke-free environments, 
increasing cessation measures to help current 
smokers to quit, and preventing smoking initia-
tion among adolescents and young adults.
Associations of urine cadmium with deter-
minants other than smoking were also consis-
tent with those in other populations, including 
higher cadmium concentrations with increas-
ing age and among women, individuals with 
less than a high school education, and indi-
viduals with occupations related to cadmium 
exposure (Nordberg et al. 2007; Vahter et al. 
2007). BMI showed an inverse association with 
urine cadmium concentrations. This association 
has been previously reported (Dhooge et al. 
2010; Friedman et al. 2006; Padilla et al. 2010), 
although there is limited evidence providing a 
biological explanation for this finding. Changes 
in these determinants over time, however, con-
tributed little to the reduction in urine cad-
mium concentrations. Occupation, for instance, 
is a modifiable source of cadmium exposure that 
was associated with urine cadmium concentra-
tions in all study surveys but did not explain 
changes in urine cadmium concentrations over 
time. Given the well-  described health effects 
of cadmium in occupational settings (ATSDR 
1999; IARC 1993; Nordberg et al. 2007), addi-
tional exposure prevention efforts, including the 
implementation of the Occupational Safety and 
Health Administration recommendations for 
cadmium-associated occupations, are impor-
tant to reduce and prevent cadmium exposure 
in occupational settings (U.S. Department of 
Labor 2010).
In subgroup analysis, African-American 
participants and participants with less than 
high school education presented larger reduc-
tions compared with other subgroups. For 
African Americans, urine cadmium concen-
trations changed from being higher than 
concentrations in whites in 1988–1994 to 
being similar to concentrations in whites in 
2003–2008. For individuals with less educa-
tion, urine cadmium concentrations in 2003–
2008 remained higher than concentrations in 
more educated individuals. We could not eval-
uate the contribution of changes in cadmium 
exposure through diet and ambient air, because 
long-term individual exposure to cadmium 
from diet cannot be estimated from NHANES 
24-hr recall questionnaires, and data on cad-
mium exposure information from air are not 
available. The U.S. EPA air pollution program 
did not systematically monitor air cadmium 
levels in cities over the entire study period, 
but there is evidence that cadmium produc-
tion and particulate matter emissions from 
metal-processing industries started to decrease 
in the United States in the 1970s (U.S. EPA 
2010b; USGS 2010). Nationwide environ-
mental monitoring programs have shown a 
progressive decline in cadmium concentrations 
in biological specimens, in sediments, and 
in great lakes and coastal waters (O’Connor 
and Lauenstein 2006; U.S. Center for Coastal 
Monitoring and Assessment 2010; U.S. EPA 
2011). Cadmium content in U.S. food markets 
has also been decreasing since 1990 (U.S. Food 
and Drug Administration 2010). It is thus pos-
sible that part of the reduction in urine cad-
mium concentrations found in this study was 
related to an overall decrease in environmental 
and dietary cadmium concentrations. Future 
studies monitoring cadmium exposure and its 
determinants should incorporate individual 
data on exposure from diet and ambient air. It 
is also important to evaluate the environmental 
impact and contribution to human exposure 
of non  recycled cadmium-containing products 
(e.g., batteries, electronic devices, jewelry, and 
toys) and of cadmium-containing fertilizers 
(Mead 2010; USGS 2010).
In addition to the lack of information on 
cadmium exposure through diet and air, it is 
possible that changes in laboratory methods 
over time could have affected the observed 
trends in urine cadmium levels. Specially, 
changes in laboratory methods could be partly 
responsible of the residual trend that could not 
be attributed to the available determinants. 
However, urine cadmium was measured in the 
same laboratory under strict quality control 
measures with the goal of tracking concentra-
tions over time. Other sources of nondiffer-
ential error by time, including random error 
or individual variation attributable to toxico-
kinetic factors independent from age, sex, race/
ethnicity, renal function, or iron status could 
potentially bias the trend estimates toward the 
null. Consequently, having individual repeated 
measurements could help to improve the esti-
mates. Additionally, the variables used to meas-
ure smoking and exposure to tobacco smoke 
may not fully capture lifetime cumulative 
exposure to tobacco; therefore, the propor-
tion of the decline in cadmium concentrations 
attributed to smoking may be biased.
Finally, our analysis has important 
strengths, including the large sample size that 
enabled us to conduct interaction models by 
survey and cadmium-determinant subgroups, 
including race/ethnicity; the availability of 
detailed information on relevant cadmium 
determinants, such as smoking; the standard-
ization of the study protocol; the extensive 
laboratory quality control; and the representa-
tiveness of the study sample.
Conclusion
Cadmium exposure, as measured in urine, sub-
stantially decreased in U.S. adults from 1988 
to 2008. Our data suggest that declining smok-
ing rates and exposure to tobacco smoke have 
contributed to reducing cadmium exposure in 
the United States, and that fewer people have 
urine cadmium at levels above the reference 
point proposed by the European Food Safety 
Authority (EFSA 2011) for the estimation of 
the tolerable weekly intake. However, cad-
mium remains a concern because of evidence 
indicating toxicity at the current levels of envi-
ronmental exposure. For example, even at the 
reduced recent levels of exposure, cadmium has 
been related to cardiovascular, bone, and kid-
ney disease in studies of NHANES 1999–2008 
data (Egwuogu et al. 2009; Gallagher et al. 
2008; Navas-Acien et al. 2004, 2005, 2009; 
Peters et al. 2010; Tellez-Plaza et al. 2008, Cadmium reduction in the U.S. population
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2010), supporting the need to further reduce 
cadmium exposure. Because the epidemiologic 
evidence available is mostly cross-sectional, 
prospective epidemiologic studies are needed 
to understand the health consequences of cad-
mium exposure and to evaluate the adequacy 
of current food and environmental safety stan-
dards. Additional public health efforts, includ-
ing tobacco control interventions and efforts 
to reduce levels of cadmium in air, soils, and 
food, are critical to further prevent cadmium 
exposure in the general population.
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